Strides Pharma Science Ltd (IN:STAR)
:STAR
Want to see IN:STAR full AI Analyst Report?
Total Valuation
Strides Pharma Science Ltd has a market cap or net worth of ₹106.28B. The enterprise value is ₹121.74B.
Market Cap₹106.28B
Enterprise Value₹121.74B
Share Statistics
Strides Pharma Science Ltd has 92,172,714 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding92,172,714
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Strides Pharma Science Ltd’s return on equity (ROE) is 0.18 and return on invested capital (ROIC) is 11.98%.
Return on Equity (ROE)0.18
Return on Assets (ROA)0.08
Return on Invested Capital (ROIC)11.98%
Return on Capital Employed (ROCE)0.18
Revenue Per Employee15.85M
Profits Per Employee1.81M
Employee Count3,065
Asset Turnover0.70
Inventory Turnover1.89
Valuation Ratios
The current PE Ratio of Strides Pharma Science Ltd is 17.0. Strides Pharma Science Ltd’s PEG ratio is 0.42.
PE Ratio17.0
PS Ratio1.78
PB Ratio2.78
Price to Fair Value2.78
Price to FCF71.30
Price to Operating Cash Flow27.16
PEG Ratio0.42
Income Statement
In the last 12 months, Strides Pharma Science Ltd had revenue of 48.59B and earned 5.56B in profits. Earnings per share was 60.34.
Revenue48.59B
Gross Profit17.69B
Operating Income7.23B
Pretax Income6.69B
Net Income5.56B
EBITDA9.25B
Earnings Per Share (EPS)60.34
Cash Flow
In the last 12 months, operating cash flow was 3.91B and capital expenditures -1.49B, giving a free cash flow of 2.42B billion.
Operating Cash Flow3.91B
Free Cash Flow2.42B
Free Cash Flow per Share26.29
Dividends & Yields
Strides Pharma Science Ltd pays an annual dividend of ₹4, resulting in a dividend yield of 0.41%
Dividend Per Share₹4
Dividend Yield0.41%
Payout Ratio9.15%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.79
52-Week Price Change64.05%
50-Day Moving Average1.01K
200-Day Moving Average910.30
Relative Strength Index (RSI)70.47
Average Volume (3m)12.54K
Important Dates
Strides Pharma Science Ltd upcoming earnings date is Aug 5, 2026, TBA (Confirmed).
Last Earnings DateMay 18, 2026
Next Earnings DateAug 5, 2026
Ex-Dividend Date―
Financial Position
Strides Pharma Science Ltd as a current ratio of 1.25, with Debt / Equity ratio of 56.57%
Current Ratio1.25
Quick Ratio0.68
Debt to Market Cap0.20
Net Debt to EBITDA1.67
Interest Coverage Ratio4.05
Taxes
In the past 12 months, Strides Pharma Science Ltd has paid 941.66M in taxes.
Income Tax941.66M
Effective Tax Rate0.14
Enterprise Valuation
Strides Pharma Science Ltd EV to EBITDA ratio is 11.01, with an EV/FCF ratio of 84.04.
EV to Sales2.10
EV to EBITDA11.01
EV to Free Cash Flow84.04
EV to Operating Cash Flow18.90
Balance Sheet
Strides Pharma Science Ltd has ₹2.27B in cash and marketable securities with ₹18.44B in debt, giving a net cash position of -₹16.16B billion.
Cash & Marketable Securities₹2.27B
Total Debt₹18.44B
Net Cash-₹16.16B
Net Cash Per Share-₹175.37
Tangible Book Value Per Share₹190.42
Margins
Gross margin is 36.40%, with operating margin of 14.88%, and net profit margin of 11.45%.
Gross Margin36.40%
Operating Margin14.88%
Pretax Margin13.76%
Net Profit Margin11.45%
EBITDA Margin19.04%
EBIT Margin14.88%
Analyst Forecast
The average price target for Strides Pharma Science Ltd is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast4.88%
EPS Growth Forecast66.43%